MET and neoplasm: For example, monotherapy with MET inhibitors was found to induce tumor growth inhibition only in a cohort of patient-derived xenografts from a poorly differentiated adenocarcinoma of the GEJ with c-met amplification, but no EGFR molecular alterations.